Marc Kirchmeier

Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies

Roxana Ionescu, Josef Vlasak, Colleen Price et al. · Journal of Pharmaceutical Sciences · 2007 · 315 citations

Autoimmune Disease, Immunology, Immunodominance +13

Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody

Josef Vlasak, Marie Claire Bussat, Shi‐Yi Wang et al. · Analytical Biochemistry · 2009 · 242 citations

Immunocytochemical Technique, Allergy, Autoimmune Disease +12

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells

Tatsuhiro Ishida, Marc Kirchmeier, Elaine H. Moase et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2001 · 210 citations

Cell-based Drug Delivery, Lymphoid Neoplasia, Drug Targeting +7

Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity

Marc Kirchmeier, Anne-Catherine Fluckiger, Catalina Soare et al. · Clinical and Vaccine Immunology · 2013 · 87 citations · Full text

Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells

Daniel E. Lopes de Menezes, Marc Kirchmeier, Jean-François Gagné et al. · Journal of Liposome Research · 1999 · 71 citations

Immunology, Immunotherapy, Tumor Biology +16